About Pirfenidone API

CH₃ H₃C-O N
Therapeutic Category Anti Fibrotic
CAS Number 53179-13-8
API Technology Synthesis / Small Molecule
Dose Form Capsules / Tablets
Synergene's Development Status Available
Available Regulatory Filing ODMF

Mechanism of Action

Pirfenidone operates through targeted therapeutic pathways for anti fibrotic applications. Detailed pharmacological specifications are available upon technical request.

Indication

Indicated for pharmaceutical therapeutic applications in Anti Fibrotic disorders.